Karpathy proposes something simpler and more loosely, messily elegant than the typical enterprise solution of a vector ...
This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results